Phase II trial of seasonal influenza virus vaccine (NasoVAX)

Trial Profile

Phase II trial of seasonal influenza virus vaccine (NasoVAX)

Planning
Phase of Trial: Phase II

Latest Information Update: 04 May 2017

At a glance

  • Drugs Influenza virus vaccine (NasoVAX) (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 May 2017 According to an Altimmune media release, this study is expected to commence during 3Q of 2017 with initial data expected in 1Q of 2018.
    • 19 Jan 2017 According to a PharmAthene media release, this study is expected to commence during mid-2017 with initial data expected in the fourth quarter of 2017.
    • 24 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top